肿瘤第一线 · 学术知识传播

订阅

MedSci主页 / 所有栏目 / 肿瘤第一线 · 学术知识传播

三药联合方案治疗晚期结直肠癌的效果

2021-11-23 MedSci原创 MedSci原创

肠癌资讯阅读

结直肠癌患者确诊时约２０％以上发生远处转移，即使行根治性切除，患者也有约３５％术后复发、转移

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1971906, encodeId=392719e1906c5, content=<a href='/topic/show?id=f9c480e0860' target=_blank style='color:#2F92EE;'>#联合方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80708, encryptionId=f9c480e0860, topicName=联合方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue Jun 07 21:19:48 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985972, encodeId=651919859e24a, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59855, encryptionId=86fd59855df, topicName=晚期结直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Jan 27 07:19:48 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453616, encodeId=396a1453616ec, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Nov 25 04:19:48 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-06-07 mashirong

    #联合方案#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1971906, encodeId=392719e1906c5, content=<a href='/topic/show?id=f9c480e0860' target=_blank style='color:#2F92EE;'>#联合方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80708, encryptionId=f9c480e0860, topicName=联合方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue Jun 07 21:19:48 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985972, encodeId=651919859e24a, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59855, encryptionId=86fd59855df, topicName=晚期结直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Jan 27 07:19:48 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453616, encodeId=396a1453616ec, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Nov 25 04:19:48 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-01-27 huagfeg

    #晚期结直肠癌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1971906, encodeId=392719e1906c5, content=<a href='/topic/show?id=f9c480e0860' target=_blank style='color:#2F92EE;'>#联合方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80708, encryptionId=f9c480e0860, topicName=联合方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue Jun 07 21:19:48 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985972, encodeId=651919859e24a, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59855, encryptionId=86fd59855df, topicName=晚期结直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Thu Jan 27 07:19:48 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453616, encodeId=396a1453616ec, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Nov 25 04:19:48 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-25 crystal0564

    #结直肠#

    0

相关资讯

CUT：成年和青春期含糖饮料摄入量与女性早发性结直肠癌风险有关

在过去的20年中，许多高收入国家的早发性结直肠癌的发病率一直在上升

西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察

探讨西妥昔单抗联合 FOLFIR I 双周方案治疗 K —R as 基因野生型的晚期结直肠癌的疗效及安全性。

结肠癌病例分享

患者,47岁，女性。于2021年5月出现腹胀伴排气排便障碍。2021-5-23PET/CT:1、考虑为乙状结肠MT累及周围脂肪间隙，伴肝脏多发转移，全身多处（病变肠周、腹膜后、肝门部、右侧腋窝、左侧锁

结肠息肉内镜下黏膜切除术与高频电切术的疗效比较

【摘要】：目的研究内镜下黏膜切除术(EMR)与高频电切术在结肠息肉患者中的治疗效果。方法选取2016年2月-2018年12月在我院接受择期手术治疗的90例结肠息肉患者作为对象,按照随机数字表法分为A组

不可切除转移性结直肠癌-一线化疗解读

结直肠癌一线治疗指南更新解读

Folfoxiri方案在晚期结直肠癌中的应用

结直肠癌的发病率在世界各国尤其是发达国家中明显上升，近20年来在我国尤其是在大城市，结直肠癌的发病率已占消化道癌的第二位.